Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1038 | 956 | 1143 | 1136 | 1455 | 2009 |
Fund Return | 3.77% | -4.4% | 14.3% | 4.34% | 7.79% | 7.23% |
Place in category | 1821 | 2049 | 1794 | 722 | 367 | 160 |
% in Category | 86 | 95 | 87 | 40 | 23 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPM Global Income A acc EUR | 17.76B | 6.41 | -0.68 | 2.08 | ||
LU0740858492 | 17.76B | 6.10 | -1.03 | 1.72 | ||
JPMorgan Global Income A Div EUR | 17.76B | 6.41 | -0.68 | 2.08 | ||
JPM Global Income Fund A Mth EUR | 17.76B | 6.40 | -0.69 | - | ||
JPMorgan Global Income D div EUR | 17.76B | 6.10 | -1.03 | 1.73 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund E Acc EUR | 20.91M | 11.84 | 3.35 | 4.80 | ||
European Growth Fund Y Acc EUR | 145.45M | 13.30 | 5.02 | 6.46 | ||
European Growth Fund Y DIST EUR | 65.81M | 13.33 | 5.02 | 6.47 | ||
European Growth Fund A DIST Eue | 6.58B | 12.54 | 4.13 | 5.59 | ||
European Growth Fund A Acc EUR | 159.53M | 12.55 | 4.13 | 5.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 5.49 | 630.30 | +0.48% | |
Louis Vuitton | FR0000121014 | 4.46 | 572.40 | -4.52% | |
Novo Nordisk B | DK0062498333 | 4.35 | 748.9 | -3.23% | |
Shell | GB00BP6MXD84 | 3.58 | 30.63 | -1.83% | |
AstraZeneca | GB0009895292 | 3.10 | 9,990.0 | +0.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review